‘Under GDUFA II, FDA has committed to clean up inaccurate, inconsistent and missing information and verify data integrity’ Read more
‘Pharmaceutical manufacturers must act now to avoid production scheduling clashes’ | Dr Sanjit Singh Lamba Read more